Cargando…
Association Between Osteoprotegerin Gene Polymorphisms and Risk of Coronary Artery Disease: a Systematic Review and Meta-analysis
Osteoprotegerin (OPG) has been demonstrated to be a novel biomarker for predicting prevalence and severity of coronary artery disease (CAD). Furthermore, recent studies have shown that OPG gene polymorphisms are associated with a susceptibility to CAD. However, published studies showed inconsistent...
Autores principales: | Jia, P, Wu, N, Jia, D, Sun, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972500/ https://www.ncbi.nlm.nih.gov/pubmed/29876230 http://dx.doi.org/10.1515/bjmg-2017-0021 |
Ejemplares similares
-
Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis
por: Wu, Jine, et al.
Publicado: (2020) -
Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies
por: Vazirian, Fatemeh, et al.
Publicado: (2023) -
Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis
por: Li, Shouyi, et al.
Publicado: (2017) -
The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023) -
Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
por: Reinhard, Henrik, et al.
Publicado: (2011)